HopeStage
Back to all studies
UnknownNCT06351514

An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms

Device studyAges 21–65Singapore
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.

Listed locations
SingaporeSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 1, 2024
Recruitment status
Unknown
Enrollment listed in the registry
40
Sponsor
Institute of Mental Health, Singapore
Sponsor type
Research institute
Study type
Device
Intervention type
Device
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Singapore
Age range
From 21 Years to 65 Years
Official registry ID
NCT06351514
Official title
Show the full official title

An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms

Recruitment & locations

Status unknown

Singapore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Institute of Mental Health, Singapore, a research institute.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.

Want to explore more studies?

Explore studies